1683 related articles for article (PubMed ID: 17719150)
1. Antigenic differences among Newcastle disease virus strains of different genotypes used in vaccine formulation affect viral shedding after a virulent challenge.
Miller PJ; King DJ; Afonso CL; Suarez DL
Vaccine; 2007 Oct; 25(41):7238-46. PubMed ID: 17719150
[TBL] [Abstract][Full Text] [Related]
2. Protection of chickens against overt clinical disease and determination of viral shedding following vaccination with commercially available Newcastle disease virus vaccines upon challenge with highly virulent virus from the California 2002 exotic Newcastle disease outbreak.
Kapczynski DR; King DJ
Vaccine; 2005 May; 23(26):3424-33. PubMed ID: 15837366
[TBL] [Abstract][Full Text] [Related]
3. A vaccine candidate of attenuated genotype VII Newcastle disease virus generated by reverse genetics.
Hu S; Ma H; Wu Y; Liu W; Wang X; Liu Y; Liu X
Vaccine; 2009 Feb; 27(6):904-10. PubMed ID: 19095026
[TBL] [Abstract][Full Text] [Related]
4. Comparison of protection and viral shedding following vaccination with Newcastle disease virus strains of different genotypes used in vaccine formulation.
Wajid A; Basharat A; Bibi T; Rehmani SF
Trop Anim Health Prod; 2018 Oct; 50(7):1645-1651. PubMed ID: 29728823
[TBL] [Abstract][Full Text] [Related]
5. Effects of Newcastle disease virus vaccine antibodies on the shedding and transmission of challenge viruses.
Miller PJ; Afonso CL; El Attrache J; Dorsey KM; Courtney SC; Guo Z; Kapczynski DR
Dev Comp Immunol; 2013 Dec; 41(4):505-13. PubMed ID: 23796788
[TBL] [Abstract][Full Text] [Related]
6. Effect of phylogenetic diversity of velogenic Newcastle disease virus challenge on virus shedding post homologous and heterologous DNA vaccination in chickens.
Mohamed MH; Abdelaziz AM; Kumar S; Al-Habib MA; Megahed MM
Avian Pathol; 2016; 45(2):228-34. PubMed ID: 26813237
[TBL] [Abstract][Full Text] [Related]
7. Immune response to oil-emulsion vaccines with single or mixed antigens of Newcastle disease, avian influenza, and infectious bronchitis.
Xie ZX; Stone HD
Avian Dis; 1990; 34(1):154-62. PubMed ID: 2157390
[TBL] [Abstract][Full Text] [Related]
8. Protection and antibody response caused by turkey herpesvirus vector Newcastle disease vaccine.
Esaki M; Godoy A; Rosenberger JK; Rosenberger SC; Gardin Y; Yasuda A; Dorsey KM
Avian Dis; 2013 Dec; 57(4):750-5. PubMed ID: 24597117
[TBL] [Abstract][Full Text] [Related]
9. Efficacy in chickens of a herpesvirus of turkeys recombinant vaccine containing the fusion gene of Newcastle disease virus: onset of protection and effect of maternal antibodies.
Morgan RW; Gelb J; Pope CR; Sondermeijer PJ
Avian Dis; 1993; 37(4):1032-40. PubMed ID: 8141730
[TBL] [Abstract][Full Text] [Related]
10. Protection in specific pathogen free chickens with live avian metapneumovirus and Newcastle disease virus vaccines applied singly or in combination.
Ganapathy K; Cox WJ; Gough RE; Cargill P; Montiel E; Jones RC
Avian Pathol; 2007 Aug; 36(4):313-7. PubMed ID: 17620178
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the onset of protection induced by Newcastle disease virus strain B1 and a fowl poxvirus recombinant Newcastle disease vaccine to a viscerotropic velogenic Newcastle disease virus challenge.
King DJ
Avian Dis; 1999; 43(4):745-55. PubMed ID: 10611990
[TBL] [Abstract][Full Text] [Related]
12. Dose-response effects of inactivated Newcastle disease vaccines: influence of serologic assay, time after vaccination, and type of chickens.
Maas RA; Oei HL; Venema-Kemper S; Koch G; Bongers J
Avian Dis; 1999; 43(4):670-7. PubMed ID: 10611983
[TBL] [Abstract][Full Text] [Related]
13. In ovo vaccination of chicken embryos with experimental Newcastle disease and avian influenza oil-emulsion vaccines.
Stone H; Mitchell B; Brugh M
Avian Dis; 1997; 41(4):856-63. PubMed ID: 9454919
[TBL] [Abstract][Full Text] [Related]
14. Protective efficacy of several vaccines against highly pathogenic H5N1 avian influenza virus under experimental conditions.
Veits J; Römer-Oberdörfer A; Helferich D; Durban M; Suezer Y; Sutter G; Mettenleiter TC
Vaccine; 2008 Mar; 26(13):1688-96. PubMed ID: 18291561
[TBL] [Abstract][Full Text] [Related]
15. Protection from clinical disease against three highly virulent strains of Newcastle disease virus after in ovo application of an antibody-antigen complex vaccine in maternal antibody-positive chickens.
Kapczynski DR; Martin A; Haddad EE; King DJ
Avian Dis; 2012 Sep; 56(3):555-60. PubMed ID: 23050473
[TBL] [Abstract][Full Text] [Related]
16. Comparison of live Newcastle disease vaccines in a simple vaccination and challenge experiment.
Voeten AC; Orthel FW; Jacobs J
Res Vet Sci; 1977 Mar; 22(2):138-45. PubMed ID: 870956
[TBL] [Abstract][Full Text] [Related]
17. Comparison of viral shedding following vaccination with inactivated and live Newcastle disease vaccines formulated with wild-type and recombinant viruses.
Miller PJ; Estevez C; Yu Q; Suarez DL; King DJ
Avian Dis; 2009 Mar; 53(1):39-49. PubMed ID: 19432002
[TBL] [Abstract][Full Text] [Related]
18. Advancement in vaccination against Newcastle disease: recombinant HVT NDV provides high clinical protection and reduces challenge virus shedding with the absence of vaccine reactions.
Palya V; Kiss I; Tatár-Kis T; Mató T; Felföldi B; Gardin Y
Avian Dis; 2012 Jun; 56(2):282-7. PubMed ID: 22856183
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of combined killed-in-oil emulsion and live Newcastle disease vaccines in chickens.
Folitse R; Halvorson DA; Sivanandan V
Avian Dis; 1998; 42(1):173-8. PubMed ID: 9533096
[TBL] [Abstract][Full Text] [Related]
20. Onset and long-term duration of immunity provided by a single vaccination with a turkey herpesvirus vector ND vaccine in commercial layers.
Palya V; Tatár-Kis T; Mató T; Felföldi B; Kovács E; Gardin Y
Vet Immunol Immunopathol; 2014 Mar; 158(1-2):105-15. PubMed ID: 24368086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
